Resonance Health Valuation

Is RHT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RHT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: RHT (A$0.05) is trading below our estimate of fair value (A$0.25)

Significantly Below Fair Value: RHT is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RHT?

Key metric: As RHT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for RHT. This is calculated by dividing RHT's market cap by their current earnings.
What is RHT's PE Ratio?
PE Ratio	143.9x
Earnings	AU$169.30k
Market Cap	AU$23.90m

RHT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.4x
Enterprise Value/EBITDA	-45.4x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does RHT's PE Ratio compare to its peers?

The above table shows the PE ratio for RHT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	16x
AHC Austco Healthcare	12.3x	n/a	AU$87.4m
SDI SDI	11.6x	17.8%	AU$122.4m
AHX Apiam Animal Health	15.5x	n/a	AU$84.0m
SLA SILK Laser Australia	24.5x	28.9%	AU$177.4m
RHT Resonance Health	143.9x	n/a	AU$23.9m

Price-To-Earnings vs Peers: RHT is expensive based on its Price-To-Earnings Ratio (143.9x) compared to the peer average (13.2x).

Price to Earnings Ratio vs Industry

How does RHT's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

10 Companies	Price / Earnings	Estimated Growth	Market Cap

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: RHT is expensive based on its Price-To-Earnings Ratio (143.9x) compared to the Global Medical Equipment industry average (28x).

Price to Earnings Ratio vs Fair Ratio

What is RHT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RHT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	143.9x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate RHT's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

SDI

AU$122.4m

Engages in the research and development, manufacture, and marketing of dental restorative materials, whitening systems, and other dental materials in Australia, Europe, the United States, and Brazil.

SDI

AU$1.02

22.9%

Doctor Care Anywhere Group

AU$25.7m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.065

-3.0%

32.7%

Nova Eye Medical

AU$36.6m

Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.

EYE

AU$0.16

3.2%

14.3%